Showing results (171-180 of 194) with videos related to

Sort By:
Pageof 20
Annals of the Rheumatic Diseases|May 26, 2010
Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markersDarren Plant, Edward Flynn, Hamdi Mbarek, et al.
Clinical Immunology (Orlando, Fla.)|December 31, 2022
Early prediction of COVID-19 outcome using artificial intelligence techniques and only five laboratory indicesPanagiotis G Asteris, Styliani Kokoris, Eleni Gavriilaki, et al.
Annals of the Rheumatic Diseases|January 26, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022Kevin L Winthrop, John D Isaacs, Philip J Mease, et al.
Annals of the Rheumatic Diseases|January 30, 2019
Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosusSara K Tedeschi, Sindhu R Johnson, Dimitrios T Boumpas, et al.
Rheumatology International|March 1, 2023
Apremilast for biologic-naïve, peripheral psoriatic arthritis, including patients with early disease: results from the APROACH observational prospective studyPetros P Sfikakis, Dimitrios Vassilopoulos, Gkikas Katsifis, et al.
The Journal of Rheumatology|December 17, 2018
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification CriteriaSindhu R Johnson, Dinesh Khanna, David Daikh, et al.
Seminars in Arthritis and Rheumatism|March 21, 2018
Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational studyAntonis Fanouriakis, Christina Adamichou, Sofia Koutsoviti, et al.
Annals of the Rheumatic Diseases|March 19, 2010
Evidence for treating rheumatoid arthritis to target: results of a systematic literature searchMonika Schoels, Rachel Knevel, Daniel Aletaha, et al.
Immunobiology|February 22, 2023
Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infectionStefanos A Tsiftsoglou, Eleni Gavriilaki, Tasoula Touloumenidou, et al.
RMD Open|September 19, 2024
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational studyMaria Pappa, Maria Kosmetatou, Antigone Pieta, et al.
Pageof 20